Takeda R&D Exec Explains How $1.2B Deal Could Become One of the Biggest Bargains in Drug History
Pharmaceutical companies need to spend money in order to make money, and the looming loss of patent exclusivity for numerous products has these companies out in force striking business deals to fill their pipelines with new drugs offering blockbuster …